STATEN ISLAND, N.Y. — It was around 3:45 a.m. Friday morning when Steven Dubester, an admitted “night owl,” was sitting and streaming a series on Apple TV alongside his dog Seaver. Dubester heard a ...

A new tablet-based drug is showing great promise for both type 2 diabetes and obesity — and unlike existing GLP-1 medications, it doesn’t reduce appetite or cause muscle loss. Early studies suggest ...